Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CMPX Compass Therapeutics Inc

2,65

-0,45 (-14,52%)

25 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Compass Therapeutics Charts.

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Compass Therapeutics Charts.

News Compass Therapeutics Inc

Another Day, Another Biotech Stealing The Show
Mittwoch 8 Januar 2025 (3 Wochen vor) • AllPennyStocks.com

Form 8-K - Current report
Mittwoch 8 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate
Mittwoch 8 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 10 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 10 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 10 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
Dienstag 10 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Montag 2 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Compass Therapeutics to Participate in Upcoming Investor Events
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Freitag 8 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Compass Therapeutics Inc News-Artikel

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen